Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Optimizing Infection Control to Improve Outcomes of Allogeneic Stem Cell Transplant

Episodes

Specialty:

All

Year:

All

EP. 1: Need for Infection Control in Patients Receiving High-Dose Therapy and Allogeneic Transplant

January 16th 2017

EP. 2: Azoles for Prophylaxis of Invasive Fungal Infections in Transplant Patients

January 16th 2017

EP. 3: Monitoring Azole Levels in Transplant Patients

January 16th 2017

EP. 4: Morbidity from CMV Infection in Transplant Patients

January 16th 2017

EP. 5: The Need for CMV Prophylaxis in the Transplant Setting

January 16th 2017

EP. 6: Letermovir for CMV Prophylaxis in Transplant Patients

January 16th 2017

EP. 7: Letermovir Phase III Trial

January 16th 2017

Trending on OncLive

FDA Approves Amivantamab and Hyaluronidase for Metastatic HNSCC

BCG Optimization Becomes a Priority as Durvalumab Gains a Role in High-Risk NMIBC

Dr Cai on the Rationale for Evaluating Rocbrutinib Plus R-CHOP in Non-GCB DLBCL and MCL

Dr Skoulidis on Divarasib vs Sotorasib or Adagrasib in KRAS G12C–Mutated NSCLC

Routine Breast Imaging May Offer Little Benefit After Double Mastectomy for Early Breast Cancer